Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ILMN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeILMNIllumina$70.30-4.3%$95.52$69.38▼$156.66$11.63B1.382.24 million shs3.21 million shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceILMNIllumina-0.96%-7.42%-15.20%-47.19%-42.50%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationILMNIllumina4.6726 of 5 stars4.25.00.04.22.91.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceILMNIllumina 2.48Hold$139.8598.93% UpsideCurrent Analyst Ratings BreakdownLatest ILMN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/8/2025ILMNIlluminaRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$128.00 ➝ $112.004/7/2025ILMNIlluminaCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$90.00 ➝ $85.003/12/2025ILMNIlluminaRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$247.00 ➝ $128.003/11/2025ILMNIlluminaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight ➝ Underweight3/11/2025ILMNIlluminaStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$156.00 ➝ $156.003/11/2025ILMNIlluminaCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$135.00 ➝ $115.003/5/2025ILMNIlluminaRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$127.00 ➝ $90.003/4/2025ILMNIlluminaCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$130.00 ➝ $90.002/28/2025ILMNIlluminaHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold2/28/2025ILMNIlluminaHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$100.00(Data available from 4/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookILMNIllumina$4.37B2.55$3.39 per share20.72$14.98 per share4.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateILMNIllumina-$1.22B-$7.68N/A13.621.60-27.95%13.37%5.49%5/1/2025 (Estimated)Latest ILMN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025ILMNIllumina$0.94N/AN/AN/A$1.03 billionN/A2/6/2025Q4 2024ILMNIllumina$0.92$0.86-$0.06$1.17$1.08 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthILMNIlluminaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioILMNIllumina0.631.771.42Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipILMNIllumina89.42%Insider OwnershipCompanyInsider OwnershipILMNIllumina0.17%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableILMNIllumina9,030158.40 million158.13 millionOptionableILMN HeadlinesRecent News About These CompaniesSnowflake Unveils Apache Iceberg™ Innovations, Giving Enterprises the Best of Open Data and AI-Ready PerformanceApril 8 at 9:20 AM | financialpost.comIllumina, Inc. (NASDAQ:ILMN) is Aster Capital Management DIFC Ltd's 9th Largest PositionApril 8 at 6:33 AM | marketbeat.comDynamic Technology Lab Private Ltd Increases Stock Position in Illumina, Inc. (NASDAQ:ILMN)April 8 at 5:22 AM | marketbeat.comArrowstreet Capital Limited Partnership Buys New Holdings in Illumina, Inc. (NASDAQ:ILMN)April 8 at 3:47 AM | marketbeat.comCitigroup Lowers Illumina (NASDAQ:ILMN) Price Target to $85.00April 8 at 2:29 AM | americanbankingnews.comIllumina, Inc. (NASDAQ:ILMN) Receives $140.90 Average Price Target from AnalystsApril 8 at 1:49 AM | americanbankingnews.comIllumina price target lowered to $85 from $90 at CitiApril 7 at 9:19 PM | markets.businessinsider.comWestpac Banking Corp Decreases Stock Position in Illumina, Inc. (NASDAQ:ILMN)April 7 at 4:55 AM | marketbeat.comMassachusetts Financial Services Co. MA Has $109.28 Million Position in Illumina, Inc. (NASDAQ:ILMN)April 7 at 4:45 AM | marketbeat.comGeode Capital Management LLC Has $364.67 Million Position in Illumina, Inc. (NASDAQ:ILMN)April 7 at 4:28 AM | marketbeat.comFranklin Resources Inc. Has $30.51 Million Stock Position in Illumina, Inc. (NASDAQ:ILMN)April 7 at 4:13 AM | marketbeat.comIllumina, Inc. (NASDAQ:ILMN) Receives Average Rating of "Hold" from BrokeragesApril 6 at 2:09 AM | marketbeat.comIllumina (NASDAQ:ILMN) Sets New 12-Month Low - Here's What HappenedApril 5 at 5:51 PM | marketbeat.comUniting Wealth Partners LLC Acquires New Shares in Illumina, Inc. (NASDAQ:ILMN)April 5 at 6:48 AM | marketbeat.comIllumina, Inc. (NASDAQ:ILMN) Shares Sold by DF Dent & Co. Inc.April 5 at 6:39 AM | marketbeat.comLPL Financial LLC Raises Stock Position in Illumina, Inc. (NASDAQ:ILMN)April 5 at 3:21 AM | marketbeat.comHere's Why Illumina (ILMN) is a Strong Value StockApril 4, 2025 | zacks.comIllumina, Inc. (NASDAQ:ILMN) Shares Sold by California Public Employees Retirement SystemApril 4, 2025 | marketbeat.comIllumina, Inc. (NASDAQ:ILMN) Shares Purchased by Schroder Investment Management GroupApril 4, 2025 | marketbeat.comScholtz & Company LLC Purchases Shares of 21,280 Illumina, Inc. (NASDAQ:ILMN)April 3, 2025 | marketbeat.comIllumina, Inc. (NASDAQ:ILMN) Shares Sold by Boston Family Office LLCApril 3, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeILMN Company DescriptionsIllumina NASDAQ:ILMN$70.30 -3.15 (-4.29%) Closing price 04:00 PM EasternExtended Trading$70.30 0.00 (0.00%) As of 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Qualcomm Breaks Down But RSI Signals It’s Severely Oversold Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy Will CrowdStrike's Goodwill Strategy Pay Off in Revenue Gains? Intel-Taiwan Semiconductor Alliance Fuels Turnaround Hopes Options Activity Points to More Volatility for Palantir Stock NVIDIA Stock: Oversold, Undervalued — How Low Can It Go? MicroStrategy Sees Insider Buy-Sell Action in Q1 Buffett’s Next Oil Bet: Why Occidental Is Different Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
